Trasforma questa posizione in un colloquio — un curriculum e una lettera di presentazione creati in base a ciò questo datore di lavoro sta cercando.
Nova In Silico is a health tech company in Lyon developing an in silico clinical trial platform, jinkō, to simulate drug efficacy and optimize clinical development using virtual patients and disease modeling. We offer a dynamic environment with significant responsibility for interns and a steep learning curve.
As part of a multidisciplinary team, you will conduct literature reviews, implement model components, calibrate to data, and evaluate model performance, gaining hands-on experience in QSP
Nova In Silico is a health tech company that develops an in silico clinical trial platform jinkō to simulate drug efficacy and optimize clinical development using virtual patients and disease modeling. As an innovative company, we offer a dynamic work environment distinct from larger, established organizations. Interns will gain significant responsibilities and benefit from a steep learning curve, supported by a highly motivated team.
Quantitative Systems Pharmacology, Biomodelling, Drug R&D, QSP Modeling, Oncology
Quantitative Systems Pharmacology (QSP) is a cornerstone of modern, data-driven drug development. It utilizes mechanistic mathematical models to simulate the complex, dynamic interactions between a drug, the human body, and the disease process. At Nova In Silico, we specialize in building these high-fidelity QSP models to help de-risk and accelerate the path of new medicines to the clinic.
The field of oncology, a primary focus of our work, is currently experiencing a profound revolution. The therapeutic landscape has expanded far beyond traditional small-molecule chemotherapy. We are now seeing the rise of novel therapeutic modalities, each with its own unique and highly complex mechanism of action. These include:
These therapies do not operate on simple "target-binding-effect" principles. Their efficacy and safety are governed by intricate, multi-scale biological processes, such as immune cell trafficking and activation, competition for target binding, tumor microenvironment interactions, and complex intracellular dynamics.
To accurately predict the clinical behavior of these innovative drugs, our QSP models must evolve. Standard pharmacokinetic/pharmacodynamic (PK/PD) models are often insufficient to capture this new biology. Therefore, a critical R&D objective for our team is to develop, validate, and internalize a robust library of model components specifically designed for these novel modalities. Building this internal library will enhance our platform's capabilities, allowing us to more rapidly and accurately build next-generation QSP models for our internal and client-facing projects.
Contribute directly to the strategic expansion of our internal QSP model library for novel oncology therapeutics. The intern will be responsible for the end-to-end development and/or the improvement of a mechanistic model for a specific, high-priority drug class.
We mainly use internal tools (jinkō platform) for creating the models, and R for result analysis. We are looking for people who know some of the following fields or are eager to learn and work with them:
A professional English level (written and oral) is required for this role.